Marjut Niinivirta
Researcher at Department of Immunology, Genetics and Pathology; Research programme: Cancer Immunotherapy; Research group Gustav Ullenhag
- E-mail:
- marjut.niinivirta@igp.uu.se
- Visiting address:
- Akademiska sjukhuset, ingång 100/101
751 85 Uppsala - Postal address:
- Akademiska sjukhuset, ingång 100/101
751 85 Uppsala
Publications
Recent publications
Tumor endothelial ELTD1 as a predictive marker for treatment of renal cancer patients with sunitinib
Part of BMC Cancer, 2020
- DOI for Tumor endothelial ELTD1 as a predictive marker for treatment of renal cancer patients with sunitinib
- Download full text (pdf) of Tumor endothelial ELTD1 as a predictive marker for treatment of renal cancer patients with sunitinib
Part of Journal of Cancer, p. 3224-3231, 2019
- DOI for Tumoral pyruvate kinase L/R as a predictive marker for the treatment of renal cancer patients with sunitinib and sorafenib
- Download full text (pdf) of Tumoral pyruvate kinase L/R as a predictive marker for the treatment of renal cancer patients with sunitinib and sorafenib
Intratumoral Predictive Markers in Metastatic Renal Cancer Patients
2018
Part of BMC Cancer, 2017
- DOI for A systematic search strategy identifies cubilin as independent prognostic marker for renal cell carcinoma
- Download full text (pdf) of A systematic search strategy identifies cubilin as independent prognostic marker for renal cell carcinoma
Tumoral ANXA1 Is a Predictive Marker for Sunitinib Treatment of Renal Cancer Patients
Part of Journal of Cancer, p. 3975-3983, 2017
- DOI for Tumoral ANXA1 Is a Predictive Marker for Sunitinib Treatment of Renal Cancer Patients
- Download full text (pdf) of Tumoral ANXA1 Is a Predictive Marker for Sunitinib Treatment of Renal Cancer Patients
All publications
Articles in journal
Tumor endothelial ELTD1 as a predictive marker for treatment of renal cancer patients with sunitinib
Part of BMC Cancer, 2020
- DOI for Tumor endothelial ELTD1 as a predictive marker for treatment of renal cancer patients with sunitinib
- Download full text (pdf) of Tumor endothelial ELTD1 as a predictive marker for treatment of renal cancer patients with sunitinib
Part of Journal of Cancer, p. 3224-3231, 2019
- DOI for Tumoral pyruvate kinase L/R as a predictive marker for the treatment of renal cancer patients with sunitinib and sorafenib
- Download full text (pdf) of Tumoral pyruvate kinase L/R as a predictive marker for the treatment of renal cancer patients with sunitinib and sorafenib
Part of BMC Cancer, 2017
- DOI for A systematic search strategy identifies cubilin as independent prognostic marker for renal cell carcinoma
- Download full text (pdf) of A systematic search strategy identifies cubilin as independent prognostic marker for renal cell carcinoma
Tumoral ANXA1 Is a Predictive Marker for Sunitinib Treatment of Renal Cancer Patients
Part of Journal of Cancer, p. 3975-3983, 2017
- DOI for Tumoral ANXA1 Is a Predictive Marker for Sunitinib Treatment of Renal Cancer Patients
- Download full text (pdf) of Tumoral ANXA1 Is a Predictive Marker for Sunitinib Treatment of Renal Cancer Patients
Part of Journal of Cancer Research and Clinical Oncology, p. 961-970, 2017
- DOI for Tumoral cubilin is a predictive marker for treatment of renal cancer patients with sunitinib and sorafenib
- Download full text (pdf) of Tumoral cubilin is a predictive marker for treatment of renal cancer patients with sunitinib and sorafenib